Lv01
0 积分 2021-11-11 加入
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
1小时前
待确认
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
1小时前
已完结
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
1小时前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
2小时前
已完结
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
4个月前
已完结
Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients
4个月前
已关闭
中国血糖监测临床应用指南(2011年版),中华糖尿病杂志.2011;3(1):13-21
4个月前
已完结
Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients
4个月前
已关闭
中国糖尿病患者胰岛素使用教育管理规范
4个月前
已关闭
糖皮质激素对非小细胞肺癌患者接受免疫检查点抑制剂的疗效影响
4个月前
已完结
皖公网安备34019202002308
